Protein and Peptide Therapeutics Market Size, Share, Value and Forecast 2034
Protein and Peptide Therapeutics Market By Product Type (Innovative Peptides, Genetic Peptides, and Biosimilars), By Molecular/Drug Class Type (Hormonal Peptides, Monoclonal Antibodies, and Insulin & Insulin Analogs), By Route of Administration (Oral, Parenteral, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 229 Report Code: ZMR-10500
Published Date: Apr-2026 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 318.43 Billion | USD 578.36 Billion | 6.86% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Protein and Peptide Therapeutics Market, (2025 - 2034) (USD Billion)
- 2.2 Global Protein and Peptide Therapeutics Market : snapshot
- Chapter 3. Global Protein and Peptide Therapeutics Market - Industry Analysis
- 3.1 Protein and Peptide Therapeutics Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Growing healthcare investments worldwide are working in favor of the industry players
- 3.3 Market Restraints
- 3.3.1. Cost barriers affect growth in the protein and peptide therapeutics market
- 3.4 Market Opportunities
- 3.4.1. Advancements in novel drug delivery systems offer growth opportunities to the industry players
- 3.5 Market Challenges
- 3.5.1. The inherent limitations of the drugs limit the protein and peptide therapeutics industry
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Product Type
- 3.7.2 Market attractiveness analysis By Molecular/Drug Class Type
- 3.7.3 Market attractiveness analysis By Route of Administration
- Chapter 4. Global Protein and Peptide Therapeutics Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Protein and Peptide Therapeutics Market: company market share, 2024
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Protein and Peptide Therapeutics Market - Product Type Analysis
- 5.1 Global Protein and Peptide Therapeutics Market overview: By Product Type
- 5.1.1 Global Protein and Peptide Therapeutics Market share, By Product Type, 2024 and 2034
- 5.2 Innovative Peptides
- 5.2.1 Global Protein and Peptide Therapeutics Market by Innovative Peptides, 2025 - 2034 (USD Billion)
- 5.3 Genetic Peptides
- 5.3.1 Global Protein and Peptide Therapeutics Market by Genetic Peptides, 2025 - 2034 (USD Billion)
- 5.4 Biosimilars
- 5.4.1 Global Protein and Peptide Therapeutics Market by Biosimilars, 2025 - 2034 (USD Billion)
- 5.1 Global Protein and Peptide Therapeutics Market overview: By Product Type
- Chapter 6. Global Protein and Peptide Therapeutics Market - Molecular/Drug Class Type Analysis
- 6.1 Global Protein and Peptide Therapeutics Market overview: By Molecular/Drug Class Type
- 6.1.1 Global Protein and Peptide Therapeutics Market share, By Molecular/Drug Class Type, 2024 and 2034
- 6.2 Hormonal Peptides
- 6.2.1 Global Protein and Peptide Therapeutics Market by Hormonal Peptides, 2025 - 2034 (USD Billion)
- 6.3 Monoclonal Antibodies
- 6.3.1 Global Protein and Peptide Therapeutics Market by Monoclonal Antibodies, 2025 - 2034 (USD Billion)
- 6.4 Insulin & Insulin Analogs
- 6.4.1 Global Protein and Peptide Therapeutics Market by Insulin & Insulin Analogs, 2025 - 2034 (USD Billion)
- 6.1 Global Protein and Peptide Therapeutics Market overview: By Molecular/Drug Class Type
- Chapter 7. Global Protein and Peptide Therapeutics Market - Route of Administration Analysis
- 7.1 Global Protein and Peptide Therapeutics Market overview: By Route of Administration
- 7.1.1 Global Protein and Peptide Therapeutics Market share, By Route of Administration, 2024 and 2034
- 7.2 Oral
- 7.2.1 Global Protein and Peptide Therapeutics Market by Oral, 2025 - 2034 (USD Billion)
- 7.3 Parenteral
- 7.3.1 Global Protein and Peptide Therapeutics Market by Parenteral, 2025 - 2034 (USD Billion)
- 7.4 Others
- 7.4.1 Global Protein and Peptide Therapeutics Market by Others, 2025 - 2034 (USD Billion)
- 7.1 Global Protein and Peptide Therapeutics Market overview: By Route of Administration
- Chapter 8. Protein and Peptide Therapeutics Market - Regional Analysis
- 8.1 Global Protein and Peptide Therapeutics Market Regional Overview
- 8.2 Global Protein and Peptide Therapeutics Market Share, by Region, 2024 & 2034 (USD Billion)
- 8.3. North America
- 8.3.1 North America Protein and Peptide Therapeutics Market, 2025 - 2034 (USD Billion)
- 8.3.1.1 North America Protein and Peptide Therapeutics Market, by Country, 2025 - 2034 (USD Billion)
- 8.3.1 North America Protein and Peptide Therapeutics Market, 2025 - 2034 (USD Billion)
- 8.4 North America Protein and Peptide Therapeutics Market, by Product Type, 2025 - 2034
- 8.4.1 North America Protein and Peptide Therapeutics Market, by Product Type, 2025 - 2034 (USD Billion)
- 8.5 North America Protein and Peptide Therapeutics Market, by Molecular/Drug Class Type, 2025 - 2034
- 8.5.1 North America Protein and Peptide Therapeutics Market, by Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 8.6 North America Protein and Peptide Therapeutics Market, by Route of Administration, 2025 - 2034
- 8.6.1 North America Protein and Peptide Therapeutics Market, by Route of Administration, 2025 - 2034 (USD Billion)
- 8.4. Europe
- 8.4.2 Europe Protein and Peptide Therapeutics Market, 2025 - 2034 (USD Billion)
- 8.4.2.1 Europe Protein and Peptide Therapeutics Market, by Country, 2025 - 2034 (USD Billion)
- 8.4.2 Europe Protein and Peptide Therapeutics Market, 2025 - 2034 (USD Billion)
- 8.4 Europe Protein and Peptide Therapeutics Market, by Product Type, 2025 - 2034
- 8.4.1 Europe Protein and Peptide Therapeutics Market, by Product Type, 2025 - 2034 (USD Billion)
- 8.5 Europe Protein and Peptide Therapeutics Market, by Molecular/Drug Class Type, 2025 - 2034
- 8.5.1 Europe Protein and Peptide Therapeutics Market, by Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 8.6 Europe Protein and Peptide Therapeutics Market, by Route of Administration, 2025 - 2034
- 8.6.1 Europe Protein and Peptide Therapeutics Market, by Route of Administration, 2025 - 2034 (USD Billion)
- 8.5. Asia Pacific
- 8.5.3 Asia Pacific Protein and Peptide Therapeutics Market, 2025 - 2034 (USD Billion)
- 8.5.3.1 Asia Pacific Protein and Peptide Therapeutics Market, by Country, 2025 - 2034 (USD Billion)
- 8.5.3 Asia Pacific Protein and Peptide Therapeutics Market, 2025 - 2034 (USD Billion)
- 8.4 Asia Pacific Protein and Peptide Therapeutics Market, by Product Type, 2025 - 2034
- 8.4.1 Asia Pacific Protein and Peptide Therapeutics Market, by Product Type, 2025 - 2034 (USD Billion)
- 8.5 Asia Pacific Protein and Peptide Therapeutics Market, by Molecular/Drug Class Type, 2025 - 2034
- 8.5.1 Asia Pacific Protein and Peptide Therapeutics Market, by Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 8.6 Asia Pacific Protein and Peptide Therapeutics Market, by Route of Administration, 2025 - 2034
- 8.6.1 Asia Pacific Protein and Peptide Therapeutics Market, by Route of Administration, 2025 - 2034 (USD Billion)
- 8.6. Latin America
- 8.6.4 Latin America Protein and Peptide Therapeutics Market, 2025 - 2034 (USD Billion)
- 8.6.4.1 Latin America Protein and Peptide Therapeutics Market, by Country, 2025 - 2034 (USD Billion)
- 8.6.4 Latin America Protein and Peptide Therapeutics Market, 2025 - 2034 (USD Billion)
- 8.4 Latin America Protein and Peptide Therapeutics Market, by Product Type, 2025 - 2034
- 8.4.1 Latin America Protein and Peptide Therapeutics Market, by Product Type, 2025 - 2034 (USD Billion)
- 8.5 Latin America Protein and Peptide Therapeutics Market, by Molecular/Drug Class Type, 2025 - 2034
- 8.5.1 Latin America Protein and Peptide Therapeutics Market, by Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 8.6 Latin America Protein and Peptide Therapeutics Market, by Route of Administration, 2025 - 2034
- 8.6.1 Latin America Protein and Peptide Therapeutics Market, by Route of Administration, 2025 - 2034 (USD Billion)
- 8.7. The Middle-East and Africa
- 8.7.5 The Middle-East and Africa Protein and Peptide Therapeutics Market, 2025 - 2034 (USD Billion)
- 8.7.5.1 The Middle-East and Africa Protein and Peptide Therapeutics Market, by Country, 2025 - 2034 (USD Billion)
- 8.7.5 The Middle-East and Africa Protein and Peptide Therapeutics Market, 2025 - 2034 (USD Billion)
- 8.4 The Middle-East and Africa Protein and Peptide Therapeutics Market, by Product Type, 2025 - 2034
- 8.4.1 The Middle-East and Africa Protein and Peptide Therapeutics Market, by Product Type, 2025 - 2034 (USD Billion)
- 8.5 The Middle-East and Africa Protein and Peptide Therapeutics Market, by Molecular/Drug Class Type, 2025 - 2034
- 8.5.1 The Middle-East and Africa Protein and Peptide Therapeutics Market, by Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 8.6 The Middle-East and Africa Protein and Peptide Therapeutics Market, by Route of Administration, 2025 - 2034
- 8.6.1 The Middle-East and Africa Protein and Peptide Therapeutics Market, by Route of Administration, 2025 - 2034 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 Novartis AG
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 Novo Nordisk A/S
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Takeda Pharmaceutical Company Limited
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Bristol-Myers Squibb Company
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Ferring Pharmaceuticals A/S
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 Eli Lilly and Company
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Amgen Inc.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 F. Hoffmann-La Roche Ltd
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Sanofi S.A.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Teva Pharmaceutical Industries Ltd.
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 AstraZeneca PLC
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Bachem Holding AG
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 AbbVie Inc.
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Ipsen Pharma
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Pfizer Inc.
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 and others.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.1 Novartis AG
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Protein and Peptide Therapeutics Market, 2025 - 2034 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Protein and Peptide Therapeutics Market attractiveness, By Product Type
- 6. Global Protein and Peptide Therapeutics Market attractiveness, By Molecular/Drug Class Type
- 7. Global Protein and Peptide Therapeutics Market attractiveness, By Route of Administration
- 8. Global Protein and Peptide Therapeutics Market share by Product Type, 2025 and 2034 (USD Billion)
- 9. Global Protein and Peptide Therapeutics Market by Innovative Peptides, 2025 - 2034 (USD Billion)
- 10. Global Protein and Peptide Therapeutics Market by Genetic Peptides, 2025 - 2034 (USD Billion)
- 11. Global Protein and Peptide Therapeutics Market by Biosimilars, 2025 - 2034 (USD Billion)
- 12. Global Protein and Peptide Therapeutics Market share by Molecular/Drug Class Type, 2025 and 2034 (USD Billion)
- 13. Global Protein and Peptide Therapeutics Market by Hormonal Peptides, 2025 - 2034 (USD Billion)
- 14. Global Protein and Peptide Therapeutics Market by Monoclonal Antibodies, 2025 - 2034 (USD Billion)
- 15. Global Protein and Peptide Therapeutics Market by Insulin & Insulin Analogs, 2025 - 2034 (USD Billion)
- 16. Global Protein and Peptide Therapeutics Market share by Route of Administration, 2025 and 2034 (USD Billion)
- 17. Global Protein and Peptide Therapeutics Market by Oral, 2025 - 2034 (USD Billion)
- 18. Global Protein and Peptide Therapeutics Market by Parenteral, 2025 - 2034 (USD Billion)
- 19. Global Protein and Peptide Therapeutics Market by Others, 2025 - 2034 (USD Billion)
- 20. Global Protein and Peptide Therapeutics Market share, by Region, 2025 and 2034
- 21. North America Protein and Peptide Therapeutics Market, 2025 - 2034 (USD Billion)
- 22. Europe Protein and Peptide Therapeutics Market, 2025 - 2034 (USD Billion)
- 23. Asia Pacific Protein and Peptide Therapeutics Market, 2025 - 2034 (USD Billion)
- 24. Latin America Protein and Peptide Therapeutics Market, 2025 - 2034 (USD Billion)
- 25. The Middle-East and Africa Protein and Peptide Therapeutics Market, 2025 - 2034 (USD Billion)
Table Of Tables
- 1. Global Protein and Peptide Therapeutics Market: Snapshot
- 2. Drivers of the Protein and Peptide Therapeutics Market: impact analysis
- 3. North America Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 4. North America Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 5. North America Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 6. U.S. Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 7. U.S. Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 8. U.S. Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 9. Canada Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 10. Canada Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 11. Canada Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 12. Europe Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 13. Europe Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 14. Europe Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 15. Germany Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 16. Germany Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 17. Germany Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 18. France Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 19. France Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 20. France Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 21. U.K. Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 22. U.K. Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 23. U.K. Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 24. Italy Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 25. Italy Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 26. Italy Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 27. Spain Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 28. Spain Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 29. Spain Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 30. Rest of Europe Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 31. Rest of Europe Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 32. Rest of Europe Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 33. Asia Pacific Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 34. Asia Pacific Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 35. Asia Pacific Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 36. China Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 37. China Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 38. China Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 39. Japan Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 40. Japan Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 41. Japan Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 42. India Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 43. India Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 44. India Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 45. South Korea Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 46. South Korea Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 47. South Korea Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 48. South-East Asia Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 49. South-East Asia Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 50. South-East Asia Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 51. Rest of Asia Pacific Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 52. Rest of Asia Pacific Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 53. Rest of Asia Pacific Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 54. Latin America Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 55. Latin America Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 56. Latin America Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 57. Brazil Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 58. Brazil Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 59. Brazil Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 60. Mexico Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 61. Mexico Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 62. Mexico Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 63. Rest of Latin America Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 64. Rest of Latin America Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 65. Rest of Latin America Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 66. The Middle-East and Africa Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 67. The Middle-East and Africa Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 68. The Middle-East and Africa Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 69. GCC Countries Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 70. GCC Countries Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 71. GCC Countries Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 72. South Africa Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 73. South Africa Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 74. South Africa Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 75. Rest of Middle-East Africa Protein and Peptide Therapeutics Market revenue, By Product Type, 2025 - 2034 (USD Billion)
- 76. Rest of Middle-East Africa Protein and Peptide Therapeutics Market revenue, By Molecular/Drug Class Type, 2025 - 2034 (USD Billion)
- 77. Rest of Middle-East Africa Protein and Peptide Therapeutics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
Methodology
FrequentlyAsked Questions
Protein and peptide therapeutics offer several health benefits due to high specificity, potent bioactivity, and favorable safety traits.
The global protein and peptide therapeutics market is expected to grow due to the rising prevalence of cancer across the globe.
According to study, the global protein and peptide therapeutics market size was worth around USD 318.43 billion in 2024 and is predicted to grow to around USD 578.36 billion by 2034.
The CAGR value of protein and peptide therapeutics market is expected to be around 6.86% during 2025-2034.
What are the major challenges restraining the growth of the protein and peptide therapeutics market?
The global protein and peptide therapeutics industry is expected to be challenged by the inherent limitations of the drugs.
Increasing demand for weight loss drugs and use of AI during manufacturing are the emerging trends and innovations impacting the protein and peptide therapeutics market.
North America will contribute notably towards the protein and peptide therapeutics market value.
The global protein and peptide therapeutics market is led by players like Novartis AG, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb Company, Ferring Pharmaceuticals A/S, Eli Lilly and Company, Amgen Inc., F. Hoffmann-La Roche Ltd, Sanofi S.A., Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Bachem Holding AG, AbbVie Inc., Ipsen Pharma, and Pfizer Inc.
The report explores crucial aspects of the protein and peptide therapeutics market including detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the market.
List of Contents
Protein and Peptide TherapeuticsIndustry Perspective:Key Insights:OverviewDynamicsReport ScopeSegmentationRegional AnalysisCompetitive AnalysisWhat are the latest key trends in the protein and peptide therapeutics market?The global protein and peptide therapeutics market is segmented as follows:HappyClients
